Pharmacoeconomic approaches to forecasting of the budget impact and compensation for rotavirus enteritis in children in Ukraine
Keywords:viral acute intestinal infections, rotavirus enteritis, children, “budget impact analysis”, cost compensation, vaccine prophylaxis
In the conditions of the growth of morbidity and mortality rates from enteritis of the viral origin in children, in particular rotavirus enteritis (RE), a special attention is paid to optimization of the cost for pharmacotherapy, and forecasting of possible expenses for the treatment and preventive vaccination of RE in children.
Aim. To conduct the “budget impact” analysis of pharmacotherapy and preventive vaccination of RE in children in Ukraine in 2017-2018 and predict the amount of compensation for drugs by two of the approaches to the management of the disease for 2018.
Materials and methods. The method of the “budget impact” pharmacoeconomic analysis, graphical, analytical and methods of mathematical modeling, Statistica 6 software were used.
Results. The impact on the budget due to the introduction of vaccination among children requires more costs than pharmacotherapy, namely the ratio of costs in the first year – 1:30, in the second year – 1:10. The predicted volume of
vaccination compensation in Ukraine is 772,952,274 UAH (711 UAH per a child), compensation for the cost of drugs for the treatment of RE – 3560,853 UAH. (281.49 UAH per a patient).
Conclusions. It has been found that there is a significant economic burden of vaccination on the budget; however, this method has the benefits delayed in time. The predicted total volume of compensation (reimbursement) of vaccination is significantly higher than the volume of compensation of the RE pharmacotherapy. However, the cost of vaccination per capita exceeded by 2.5 times compared to the treatment
Nakaz MOZ Ukrainy vіd 13.09.2010 r. № 769. Pro zatverdzhennia Kontseptsii rozvytku farmatsevtychnoho sektoru haluzі
okhorony zdorovia Ukrainy na 2011–2020 roky. Available at: http://moz.gov.ua/ua/portal/dn_20100913_769.html
Nakaz MOZ Ukrainy vіd 10.12.2007 r. № 803. Pro vnesennia zmіn do nakazu MOZ vіd 09.07.04 № 354. Available at: http://
WHO vaccine–preventable diseases : monitoring system. 2016 global summary. Available at : http://apps.who.int/immunization_
Lіsovyi, V. M., Bezdіtko, N. V., Yermolenko, T. I. (2015). Aktualnі pytannia farmatsevtychnoi і medychnoi nauky ta praktyky,
(18), 98–101. Available at: http://nbuv.gov.ua/UJRN/apfimntp_2015_2_23
Nemchenko, A. S., Balynska, M. V., Podhaina, M. V. (2016). Metodyka provedennia farmakoekonomіchnykh doslіdzhen terapіi
hostrykh kyshkovykh іnfektsіi u dіtei. Kharkiv, 242–243.
Vytraty u farmakoekonomіtsі. Available at : http://www.pharmencyclopedia.com.ua/article/1735/vitrati–u–farmakoekonomici
ROTARIKS™ Vaktcyna dlia profilaktiki rotavirusnoi infektsii (ROTARIX™). Available at: http://compendium.com.ua/info/171907/
Derzhavna sluzhba statystyky Ukrainy. Available at: www.ukrstat.gov.ua
Nemchenko, A. S., Podhaina, M. V., Balynska, M. V. et al. (2017). Prohnozuvannia poshyrenostі rotavіrusnoho enterytu sered
dіtei metodom matematychnoho modeliuvannia. Kharkiv: NUPh, 114–115.
Nemchenko, A. S., Balynska, M. V. (2017). Sotsіalna farmatsіia v okhoronі zdorovia, 2, 60–64.
Nemchenko, A. S., Balynska, M. V. (2017). Farmatsevtychnyi chasopys, 1 (47), 68–73.
Nemchenko, A., Podgaina, M., Balynska, M. (2016). Assesment of the Costs of Overall Children Vaccination with Antirotavirus
Vaccine in Ukraine. Vienna, Austria, 615.
Balynska, M. V., Podgaina, M. V. (2017). Structural analysis of british national formulary (for children) in part of acute diarrhea
in children treatment. Dushanbe, 365–366.
Copyright (c) 2017 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).